10052405

Source:http://linkedlifedata.com/resource/pubmed/id/10052405

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:10052405	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:10052405	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:10052405	lifeskim:mentions	umls-concept:C0008976	lld:lifeskim
pubmed-article:10052405	lifeskim:mentions	umls-concept:C0085295	lld:lifeskim
pubmed-article:10052405	lifeskim:mentions	umls-concept:C0033860	lld:lifeskim
pubmed-article:10052405	lifeskim:mentions	umls-concept:C1274040	lld:lifeskim
pubmed-article:10052405	lifeskim:mentions	umls-concept:C0205390	lld:lifeskim
pubmed-article:10052405	lifeskim:mentions	umls-concept:C0205210	lld:lifeskim
pubmed-article:10052405	pubmed:issue	2	lld:pubmed
pubmed-article:10052405	pubmed:dateCreated	1999-3-22	lld:pubmed
pubmed-article:10052405	pubmed:abstractText	To determine the safety and clinical effects of interleukin 10 (IL-10) treatment of psoriasis.	lld:pubmed
pubmed-article:10052405	pubmed:language	eng	lld:pubmed
pubmed-article:10052405	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10052405	pubmed:citationSubset	AIM	lld:pubmed
pubmed-article:10052405	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10052405	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:10052405	pubmed:month	Feb	lld:pubmed
pubmed-article:10052405	pubmed:issn	0003-987X	lld:pubmed
pubmed-article:10052405	pubmed:author	pubmed-author:FriedrichMM	lld:pubmed
pubmed-article:10052405	pubmed:author	pubmed-author:SterryWW	lld:pubmed
pubmed-article:10052405	pubmed:author	pubmed-author:EbelingMM	lld:pubmed
pubmed-article:10052405	pubmed:author	pubmed-author:DöckeW DWD	lld:pubmed
pubmed-article:10052405	pubmed:author	pubmed-author:VolkH DHD	lld:pubmed
pubmed-article:10052405	pubmed:author	pubmed-author:AudringHH	lld:pubmed
pubmed-article:10052405	pubmed:author	pubmed-author:AsadullahKK	lld:pubmed
pubmed-article:10052405	pubmed:author	pubmed-author:BelbeGG	lld:pubmed
pubmed-article:10052405	pubmed:issnType	Print	lld:pubmed
pubmed-article:10052405	pubmed:volume	135	lld:pubmed
pubmed-article:10052405	pubmed:owner	NLM	lld:pubmed
pubmed-article:10052405	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:10052405	pubmed:pagination	187-92	lld:pubmed
pubmed-article:10052405	pubmed:dateRevised	2008-3-17	lld:pubmed
pubmed-article:10052405	pubmed:meshHeading	pubmed-meshheading:10052405...	lld:pubmed
pubmed-article:10052405	pubmed:meshHeading	pubmed-meshheading:10052405...	lld:pubmed
pubmed-article:10052405	pubmed:meshHeading	pubmed-meshheading:10052405...	lld:pubmed
pubmed-article:10052405	pubmed:meshHeading	pubmed-meshheading:10052405...	lld:pubmed
pubmed-article:10052405	pubmed:meshHeading	pubmed-meshheading:10052405...	lld:pubmed
pubmed-article:10052405	pubmed:meshHeading	pubmed-meshheading:10052405...	lld:pubmed
pubmed-article:10052405	pubmed:meshHeading	pubmed-meshheading:10052405...	lld:pubmed
pubmed-article:10052405	pubmed:year	1999	lld:pubmed
pubmed-article:10052405	pubmed:articleTitle	Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial.	lld:pubmed
pubmed-article:10052405	pubmed:affiliation	Department of Dermatology, University Hospital Charité, Berlin Humboldt University, Germany.	lld:pubmed
pubmed-article:10052405	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:10052405	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:10052405	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:10052405	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:10052405	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10052405	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10052405	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10052405	lld:pubmed